Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men
Status:
Completed
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
This will be a randomized, multicenter, open-label, active-controlled, efficacy, and safety
study in adult hypogonadal men. The study duration is 12 months (365 days), including a
90-day, open-label efficacy period and a 9-month (275-day) safety evaluation period.